Clinical characteristics of patients with acute coronary syndrome at high clinical suspicion for obstructive sleep apnea syndrome

Hellenic Journal of Cardiology

Volumn 54, Issue 5, 2013, Pages 348-354

  Szymanski, Filip M ^a   Filipiak, Krzysztof J ^a   Hrynkiewicz Szymanska, Anna ^a   Karpinski, Grzegorz ^a   Opolski, Grzegorz ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Acute coronary syndromes; Cardiovascular risk factors; Clinical suspicion for obstructive sleep apnea syndrome

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; APNEA HYPOPNEA INDEX; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; DIABETES MELLITUS; EPWORTH SLEEPINESS SCALE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; HYPERTENSION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PREVALENCE; QUESTIONNAIRE; SCORING SYSTEM; SLEEP DISORDERED BREATHING; TRANSTHORACIC ECHOCARDIOGRAPHY;

ACUTE CORONARY SYNDROME; ADULT; AGED; BLOOD PRESSURE; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84885111728     PISSN: 11099666     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Wolk R, Kara T, Somers VK. Sleep-disordered breathing and cardiovascular disease. Circulation. 2003; 108: 9-12.
2. Mooe T, Rabben T, Wiklund U, Franklin KA, Eriksson P. Sleep-disordered breathing in men with coronary artery disease. Chest. 1996; 109: 659-663.
3. Schäfer H, Koehler U, Ewig S, Hasper E, Tasci S, Lüderitz B. Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology. 1999; 92: 79-84.
4. Peker Y, Kraiczi H, Hedner J, Löth S, Johansson A, Bende M. An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J. 1999; 14: 179-184.
5. Mooe T, Franklin KA, Holmström K, Rabben T, Wiklund U. Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med. 2001; 164: 1910-1913.
6. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med. 1999; 131: 485-491.
7. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991; 14: 540-545.
8. Epstein LJ, Kristo D, Strollo PJ Jr, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009; 5: 263-276.
9. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002; 165: 1217-1239.
10. Drager LF, Genta PR, Pedrosa RP, et al. Characteristics and predictors of obstructive sleep apnea in patients with systemic hypertension. Am J Cardiol. 2010; 105: 1135-1139.
11. Jonczak L, Bednarek M, Pływaczewski R, Zieliński J. [Comparison of answers to a sleep questionnaire of middle-age adults in Warsaw]. Pneumonol Alergol Pol. 2003; 71: 163-168.
12. Zieliński J, Zgierska A, Polakowska M, et al. Snoring and excessive daytime somnolence among Polish middle-aged adults. Eur Respir J. 1999; 14: 946-950.
13. Ozeke O, Güngör M, Hizel SB, et al. Influence of the severity of obstructive sleep apnea on nocturnal heart rate indices and its association with hypertension. Anadolu Kardiyol Derg. 2011; 11: 509-514.
14. Chatzistamatiou EI, Moustakas GN, Veioglanis S, et al. Nocturnal hypertension: poor correlation with office blood pressure but strong prognostic factor for target organ damage. Hellenic J Cardiol. 2012; 53: 263-272.
15. Veasey SC, Guilleminault C, Strohl KP, Sanders MH, Ballard RD, Magalang UJ. Medical therapy for obstructive sleep apnea: a review by the Medical Therapy for Obstructive Sleep Apnea Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep. 2006; 29: 1036-1044.
16. Wang TJ, Larson MG, Levy D, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation. 2004; 109: 594-600.
17. Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation. 2002; 105: 2462-2464.
18. Fleischmann G, Fillafer G, Matterer H, Skrabal F, Kotanko P. Prevalence of chronic kidney disease in patients with suspected sleep apnoea. Nephrol Dial Transplant. 2010; 25: 181-186.
19. Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004; 351: 1285-1295.
20. Yumino D, Tsurumi Y, Takagi A, Suzuki K, Kasanuki H. Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol. 2007; 99: 26-30.
21. Hrynkiewicz-Szymanska A, Szymanski FM, Filipiak KJ, et al. Can obstructive sleep apnea be a cause of in-stent thrombosis? Sleep Breath. 2011; 15: 607-609.
22. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 2003; 107: 1129-1134.
23. Kuniyoshi FH, Garcia-Touchard A, Gami AS, et al. Daynight variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol. 2008; 52: 343-346.
24. Schäfer H, Koehler U, Ploch T, Peter JH. Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease. Chest. 1997; 111: 387-393.
25. Peker Y, Hedner J, Kraiczi H, Löth S. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med. 2000; 162: 81-86.
26. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoeahypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005; 365: 1046-1053.
27. Cassar A, Morgenthaler TI, Lennon RJ, Rihal CS, Lerman A. Treatment of obstructive sleep apnea is associated with decreased cardiac death after percutaneous coronary intervention. J Am Coll Cardiol. 2007; 50: 1310-1314.
28. Sharma SK, Agrawal S, Damodaran D, et al. CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med. 2011; 365: 2277-2286.